Aix Marseille Univ, CNRS, BIP, UMR7281, 31 Chemin Joseph Aiguier, 13402, Marseille Cedex 9, France; Laboratoire de Biochimie et de Génie Enzymatique des Lipases, ENIS, Université de Sfax, 3038, Sfax, Tunisia.
Aix Marseille Univ, CNRS, BIP, UMR7281, 31 Chemin Joseph Aiguier, 13402, Marseille Cedex 9, France; Lipolytech, Zone Luminy Biotech, 163 avenue de Luminy, 13288, Marseille Cedex 09, France.
Biochimie. 2020 Feb;169:106-120. doi: 10.1016/j.biochi.2019.07.004. Epub 2019 Jul 6.
Porcine pancreatic extracts (PPE), also named pancreatin, are commonly used as a global source of pancreatic enzymes for enzyme replacement therapy in patients with exocrine pancreatic insufficiency. They are considered as a good substitute of human pancreatic enzymes and they have become a material of choice for in vitro models of digestion. Nevertheless, while the global PPE contents in lipase, protease and amylase activities are well characterized, little is known about individual enzymes. Here we characterized the lipase, phospholipase, cholesterol esterase and galactolipase activities of PPE and compared them with those of porcine (PPJ) and human (HPJ) pancreatic juices. The phospholipase to lipase activity ratio was similar in PPJ and HPJ, but was 4-fold lower in PPE. The galactolipase and cholesterol esterase activities were found at lower levels in PPJ compared to HPJ, and they were further reduced in PPE. The enzymes known to display these activities in HPJ, pancreatic lipase-related protein 2 (PLRP2) and carboxylester hydrolase/bile salt-stimulated lipase (CEH/BSSL), were identified in PPJ using gel filtration experiments, SDS-PAGE and LC-MS/MS analysis. The galactolipase and cholesterol esterase activities of PPE indicated that PLRP2 and CEH/BSSL are still present at low levels in this enzyme preparation, but they were not detected by mass spectrometry. Besides differences between porcine and human enzymes, the lower levels of phospholipase, galactolipase and cholesterol esterase activities in PPE are probably due to some proteolysis occurring during the production process. In conclusion, PPE do not provide a full substitution of the lipolytic enzymes present in HPJ.
猪胰腺提取物(PPE),也称为胰酶,通常被用作外分泌胰腺功能不全患者酶替代治疗中胰腺酶的全球来源。它们被认为是人类胰腺酶的良好替代品,并且已成为消化体外模型的首选物质。然而,虽然全球 PPE 中的脂肪酶、蛋白酶和淀粉酶活性已经得到很好的描述,但对个别酶的了解甚少。在这里,我们描述了 PPE 的脂肪酶、磷脂酶、胆固醇酯酶和半乳糖脂酶活性,并将其与猪(PPJ)和人(HPJ)胰液进行了比较。PPJ 和 HPJ 中的磷脂酶与脂肪酶活性比相似,但 PPE 中的比值低 4 倍。与 HPJ 相比,PPJ 中的半乳糖脂酶和胆固醇酯酶活性水平较低,在 PPE 中进一步降低。已知在 HPJ 中具有这些活性的酶,即胰脂肪酶相关蛋白 2(PLRP2)和羧酸酯水解酶/胆汁盐刺激的脂肪酶(CEH/BSSL),在 PPJ 中使用凝胶过滤实验、SDS-PAGE 和 LC-MS/MS 分析进行了鉴定。PPE 的半乳糖脂酶和胆固醇酯酶活性表明,PLRP2 和 CEH/BSSL 仍然以低水平存在于这种酶制剂中,但未通过质谱检测到。除了猪和人酶之间的差异外,PPE 中较低的磷脂酶、半乳糖脂酶和胆固醇酯酶活性可能是由于生产过程中发生了一些蛋白水解。总之,PPE 不能完全替代 HPJ 中存在的脂肪酶。